|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C07K 16/24 | (2006.01) |
| (11) | Number of the document | 1776142 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05770286.2 |
| Date of filing the European patent application | 2005-08-04 | |
| (97) | Date of publication of the European application | 2007-04-25 |
| (45) | Date of publication and mention of the grant of the patent | 2011-07-27 |
| (46) | Date of publication of the claims translation | 2011-11-25 |
| (86) | Number | PCT/EP2005/008470 |
| Date | 2005-08-04 |
| (87) | Number | WO 2006/013107 |
| Date | 2006-02-09 |
| (30) | Number | Date | Country code |
| 0417487 | 2004-08-05 | GB |
| (72) |
DI PADOVA, Franco, E., CH
GRAM, Hermann, DE
HOFSTETTER, Hans, CH
JESCHKE, Margit, CH
RONDEAU, Jean-Michel, FR
VAN DEN BERG, Wim, NL
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | IL-17 antagonistiniai antikūnai |
| IL-17 ANTAGONISTIC ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2024-07-18 | 347.00 EUR |